Susquehanna International Group’s 9 Meters Biopharma NMTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-23,500
Closed -$32.7K 13582
2023
Q1
$32.7K Sell
23,500
-1,000
-4% -$1.89K ﹤0.01% 11878
2022
Q4
$30.9K Buy
24,500
+19,195
+362% +$43.8K ﹤0.01% 11612
2022
Q3
$23K Sell
5,305
-3,930
-43% -$19.5K ﹤0.01% 12563
2022
Q2
$48K Sell
9,235
-2,495
-21% -$23.5K ﹤0.01% 12002
2022
Q1
$141K Buy
11,730
+805
+7% +$11K ﹤0.01% 11617
2021
Q4
$214K Buy
10,925
+2,810
+35% +$62.9K ﹤0.01% 11309
2021
Q3
$211K Sell
8,115
-26,920
-77% -$634K ﹤0.01% 11379
2021
Q2
$771K Buy
35,035
+17,445
+99% +$428K ﹤0.01% 8479
2021
Q1
$412K Buy
17,590
+16,970
+2,737% +$521K ﹤0.01% 9922
2020
Q4
$11K Buy
+620
New +$10.3K ﹤0.01% 10915

Other funds holding NMTR

Susquehanna International Group's NMTR Position: Q3 2023 in Review

Susquehanna International Group sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 17,089 shares — an estimated $11.5K sold.

Susquehanna International Group first reported a position in NMTR in Q4 2016 and held it in 10 quarters. The position peaked at $1.93M in Q1 2018. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

  • Susquehanna International Group reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
  • Susquehanna International Group sold 17,089 9 Meters Biopharma shares in Q3 2023, an estimated $11.5K.
  • Susquehanna International Group first reported a position in 9 Meters Biopharma in Q4 2016 and held it in 10 quarters.
  • Susquehanna International Group's 9 Meters Biopharma position peaked at $1.93M in Q1 2018.
  • 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.